Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GYG2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | ETAA1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | TEX19 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | PLOD3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | LRPPRC | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | ADAMTS8 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | IL22 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
mRNA | AMFR | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
mRNA | GOT2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
mRNA | FBLN2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |